Matthew Wilson, M.D., Ph.D.


Matthew Wilson, M.D., Ph.D. is an associate professor of medicine at the Vanderbilt University Medical Center and has been an active member of ASGCT since 2004. He originally joined the Society as a postdoctoral fellow and now serves on the Physical Delivery Therapeutics and Vector Development and Genome Editing committees, chairing the former in 2018-2019. His laboratory is currently focused on developing approaches and technologies for cell and gene therapy of kidney diseases.

2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.